Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sona Nanotech Inc C.SONA

Alternate Symbol(s):  SNANF

Sona Nanotech Inc. is a nanotechnology life sciences company, which is engaged in developing targeted hyperthermia therapy. The Company has developed multiple methods for the manufacturing of various types of gold nanoparticles (GNR). It is engaged in research and development of its technology for use in multiplex diagnostic testing platforms and advanced biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of cetyltrimethylammonium bromide (CTAB), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company is focused on the development of a pre-clinical nanomedical therapy for the treatment of cancer using its biocompatible GNR.


CSE:SONA - Post by User

Bullboard Posts
Post by nodealson Aug 23, 2020 3:18pm
428 Views
Post# 31443566

Unitaid FIND (EOI)

Unitaid FIND (EOI)Here are some of the items that caught my eye from the Expression of Interest;

this group includes the WHO (if they have any money left, remember the US administration cut funding)EC , France& B&M Gates foundation.

One of the main focus is manufactuering approved POC antigen, Ag RDT, tests in sufficient quanity to be delivered to low-and middle- income countries (LMICs).
  • their estimate required test, 500 million
  • 2-4 applying entities choosen during this round with more to be approved if deemed necassary. 
  • minimal requirement is WHO Traget product profile, TPP, contained in appendix 1 of the EOI. (i didn't see FDA approval)
  • they state that the group does not expect one single company to meet demand for at least 1 year.
  • from appendix 1, it appear SONA has the product requirement with one requirement being questionable,  Specifity requiring a value (> or equal to 97%) Sona is very close.
  • sensitivity required is greaterthan 80%, Sona is higher, 96%
One requirement is that you must submit the EOI in POWERPOINT in 20 or less slides. I wonder whose  insertion that belonged.


Last point is that FDA approval is not a requirement. Do the 3 approved test meet the 97% specificity limit?

I sure and and not alone on this board that is not excited. We will achieve approvals. GO SONA!!!
Bullboard Posts